Literature DB >> 34655973

Racial and Ethnic Disparities in Functional Outcome after Thrombectomy: A Cohort Study of an Integrated Stroke Network.

Erica Jones1, Aditya Kumar2, Victor Lopez-Rivera2, Jacob Sebaugh2, Haris Kamal3, Sunil A Sheth2, Anjail Sharrief4, Alicia Zha4.   

Abstract

OBJECTIVES: Previous studies have shown racial disparities in access to treatment and outcomes in ischemic stroke patients. We sought to define racial disparities in functional outcomes among ischemic stroke patients receiving endovascular thrombectomy (EVT).
MATERIALS AND METHODS: We performed a retrospective review of patients in our institution's prospectively collected stroke patient registry from 08/2015 to 06/2019 at 1 comprehensive and 2 thrombectomy-ready stroke centers. We reviewed patients aged ≥ 18 who received mechanical thrombectomy including only patients with race/ethnicity data belonging to the 3 largest race/ethnic groups: Non-Hispanic White (NHW), Non-Hispanic Black (NHB), and Hispanic (HIS). We compared baseline characteristics and performed multivariable logistic regression to evaluate differences in good functional outcome defined as 90-day modified Rankin score (90 day mRS 0-2) as the primary outcome. Secondary outcomes were discharge disposition, length of stay, and excellent functional outcome (90 day mRS 0-1). Results are given as OR [95% CI].
RESULTS: Among 666 patients that met inclusion criteria, 45% were NHW, 30% were NHB, and 19% were HIS. NHB and HIS patients were younger than NHW (average age NHB 62; HIS 64; and NHW 70; p < 0.001). Diabetes was more prevalent in NHB (32%, p = 0.02) and HIS (47%, p < 0.001) compared to NHW (23%). There were no significant racial differences in pre-morbid mRS, arrival NIHSS, tPA treatment rates. There was no difference in primary outcome by race comparing NHW to the other racial groups (OR 1.08 [0.68-1.72]) but compared to HIS patients, NHW had a higher likelihood of the secondary outcome of excellent functional outcome (aOR 2.23 [1.01-4.93]) defined as mRS 0-1.
CONCLUSIONS: In this study of over 600 patients treated with EVT, we did not find significant racial disparities in functional outcome except for less excellent functional outcome in HIS compared to NHW. Further study on disparities in post-acute stroke care is needed.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disparities; Outcomes; Racial; Thrombectomy

Mesh:

Year:  2021        PMID: 34655973      PMCID: PMC8578430          DOI: 10.1016/j.jstrokecerebrovasdis.2021.106131

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  21 in total

1.  Racial/ethnic disparities in emergency department waiting time for stroke patients in the United States.

Authors:  Sudeep J Karve; Rajesh Balkrishnan; Yousef M Mohammad; Deborah A Levine
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-06-09       Impact factor: 2.136

2.  Racial and Ethnic Disparities in the Utilization of Thrombectomy for Acute Stroke.

Authors:  Lorenzo Rinaldo; Alejandro A Rabinstein; Harry Cloft; John M Knudsen; Leonardo Rangel Castilla; Waleed Brinjikji
Journal:  Stroke       Date:  2019-08-01       Impact factor: 7.914

3.  Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.

Authors:  Gregory W Albers; Michael P Marks; Stephanie Kemp; Soren Christensen; Jenny P Tsai; Santiago Ortega-Gutierrez; Ryan A McTaggart; Michel T Torbey; May Kim-Tenser; Thabele Leslie-Mazwi; Amrou Sarraj; Scott E Kasner; Sameer A Ansari; Sharon D Yeatts; Scott Hamilton; Michael Mlynash; Jeremy J Heit; Greg Zaharchuk; Sun Kim; Janice Carrozzella; Yuko Y Palesch; Andrew M Demchuk; Roland Bammer; Philip W Lavori; Joseph P Broderick; Maarten G Lansberg
Journal:  N Engl J Med       Date:  2018-01-24       Impact factor: 91.245

Review 4.  2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  William J Powers; Alejandro A Rabinstein; Teri Ackerson; Opeolu M Adeoye; Nicholas C Bambakidis; Kyra Becker; José Biller; Michael Brown; Bart M Demaerschalk; Brian Hoh; Edward C Jauch; Chelsea S Kidwell; Thabele M Leslie-Mazwi; Bruce Ovbiagele; Phillip A Scott; Kevin N Sheth; Andrew M Southerland; Deborah V Summers; David L Tirschwell
Journal:  Stroke       Date:  2018-01-24       Impact factor: 7.914

5.  Mexican Americans Receive Less Intensive Stroke Rehabilitation Than Non-Hispanic Whites.

Authors:  Lewis B Morgenstern; Emma Sais; Michael Fuentes; Nneka L Ifejika; Xiaqing Jiang; Susan D Horn; Erin Case; Lynda D Lisabeth
Journal:  Stroke       Date:  2017-04-06       Impact factor: 7.914

6.  Race/ethnicity, quality of care, and outcomes in ischemic stroke.

Authors:  Lee H Schwamm; Mathew J Reeves; Wenqin Pan; Eric E Smith; Michael R Frankel; DaiWai Olson; Xin Zhao; Eric Peterson; Gregg C Fonarow
Journal:  Circulation       Date:  2010-03-22       Impact factor: 29.690

7.  Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials.

Authors:  Neal M Rao; Steven R Levine; Jeffrey A Gornbein; Jeffrey L Saver
Journal:  Stroke       Date:  2014-08-05       Impact factor: 7.914

8.  Racial and socioeconomic disparities in access to mechanical revascularization procedures for acute ischemic stroke.

Authors:  Frank J Attenello; Peter Adamczyk; Ge Wen; Shuhan He; Katie Zhang; Jonathan J Russin; Nerses Sanossian; Arun P Amar; William J Mack
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-05-13       Impact factor: 2.136

9.  Access to Mechanical Thrombectomy for Ischemic Stroke in the United States.

Authors:  Hooman Kamel; Neal S Parikh; Abhinaba Chatterjee; Luke K Kim; Jeffrey L Saver; Lee H Schwamm; Kori S Zachrison; Raul G Nogueira; Opeolu Adeoye; Iván Díaz; Andrew M Ryan; Ankur Pandya; Babak B Navi
Journal:  Stroke       Date:  2021-05-13       Impact factor: 10.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.